
Shortage of home COVID-19 tests hurts fight against pandemic, experts say
CBSN
The U.S. has a surplus of coronavirus vaccines. What it lacks, unlike countries in Asia and Europe, is an adequate supply of rapid COVID-19 tests that Americans can administer in the comfort of their own home.
Try to get your hands on a pack of over-the-counter COVID-19 tests at your local pharmacy and you're likely to find empty shelves. If any are in stock, they will cost roughly $24 a pair — a hefty price for many Americans. That helps explain why it is the norm for consumers to check their health status only when traveling or attending a special event, rather than using a rapid antigen test regularly, which experts say is a more effective way to contain the disease.
To alleviate the problem, the Biden administration this month announced it would invest $1 billion to expand the supply of at-home COVID-19 tests. President Joe Biden in September invoked the Defense Production Act to increase the production of rapid testing kits and help major retailers make them more accessible. He also pledged $2 billion to make roughly 280 million tests, although that amounts to less than one test a year per U.S. resident.

In the past year, over 135 million passengers traveled to the U.S. from other countries. To infectious disease experts, that represents 135 million chances for an outbreak to begin. To identify and stop the next potential pandemic, government disease detectives have been discreetly searching for viral pathogens in wastewater from airplanes. Experts are worried that these efforts may not be enough.